Physician profile
Ali Elfandi
NPI 1669816336
$5,058.36
in general payments reported to CMS, 2019-2025
34 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $618 · 2021: $606 · 2022: $840 · 2023: $2,100 · 2024: $204 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,412 · Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,412.22 |
| Food and Beverage | $1,068.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,587.29 | 2023 | Glidesheath Slender, Navicross, Glidewire |
| Janssen Pharmaceuticals, INC | $359.33 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $351.80 | 2019-2020 | |
| Penumbra, INC. | $320.39 | 2020-2025 | Indigo System |
| Novo Nordisk INC | $288.27 | 2020-2023 | Rybelsus, Ozempic |
| Amgen INC. | $232.29 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $211.79 | 2020-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $201.95 | 2020-2023 | |
| Atricure, INC. | $165.97 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $156.84 | 2021-2022 | |
| Medtronic Vascular, INC. | $140.24 | 2020 | |
| Shockwave Medical, INC | $131.35 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $102.46 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $92.98 | 2019-2023 | Brilinta |
| Inari Medical, INC. | $70.99 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $68.53 | 2022-2023 | Onpattro |
| Kestra Medical Technology Services, INC. | $67.77 | 2025 | Assure Wcd |
| Angiodynamics, INC. | $67.36 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.01 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.18 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $43.16 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $41.81 | 2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $40.55 | 2022-2025 | |
| Amarin Pharma, INC. | $28.68 | 2020 | |
| Merck Sharp & Dohme LLC | $27.92 | 2023-2024 | Verquvo |
| Medtronic, INC. | $27.22 | 2022 | |
| Impulse Dynamics (USA) INC. | $19.52 | 2023 | Optimizer |
| Abiomed | $17.87 | 2024 | Impella |
| Chiesi USA, INC. | $15.43 | 2020 | |
| Scpharmaceuticals INC. | $13.72 | 2023 | |
| Boston Scientific Corporation | $13.21 | 2021 | |
| Preventice Services, LLC | $12.23 | 2021 | |
| Lundbeck LLC | $11.90 | 2020 | |
| Surmodics, INC. | $9.35 | 2024 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Elfandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.